The Valley Desk

NCT01063829 · Interventional trial

Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients

Overall registry status Completed

Phase 2

Conditions HCMV Reactivation or HCMV End-Organ Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov